Trial intelligence / Profile preview

Mechanical bowel preparation with or without oral antibiotics prior to rectal cancer surgery

2018-004355-20Phase 4Completed

Sponsor
Helsinki University Hospital
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of neomycin and metronidazole in rectal cancer and rectal disease (not a specific disease; refers to a group of diseases affecting the rectum) (2 arms), sponsored by Helsinki University Hospital. Primary endpoint: Complications within 30 days from the surgery. Started May 2019; status: completed.

02

Drugs

neomycinmetronidazole
03

Conditions

rectal cancerrectal disease (not a specific disease; refers to a group of diseases affecting the rectum)

Beyond the preview

Go deeper on 2018-004355-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-004355-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call